https://www.yiliao.com/index.php?action=history&feed=atom&title=%E8%A1%80%E7%AE%A1%E9%9B%86%E6%9D%9F%E5%BE%81
血管集束征 - 版本历史
2026-04-20T08:28:53Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=%E8%A1%80%E7%AE%A1%E9%9B%86%E6%9D%9F%E5%BE%81&diff=315957&oldid=prev
77921020：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-27T23:19:18Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>血管集束征</strong>（Vessel Convergence Sign），又称<strong>血管切迹征</strong>或<strong>血管穿行征</strong>，是指在肺部 CT 影像上，一支或多支血管受病灶牵拉向结节聚拢、截断、包绕或穿行的征象。这一现象反映了肿瘤生长过程中对血供的强烈需求（<strong>[[血管生成]]</strong>）以及肿瘤内部纤维化对周围组织的机械牵拉。血管集束征是[[周围型肺癌]]的重要恶性征象，研究表明，出现血管穿行或血管管径增粗的结节，其恶性概率显著高于血管受压推移的结节。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 100%; max-width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">血管集束征</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">Vessel Convergence Sign (点击展开)</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
<div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 20px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);"><br />
[[Image:Vessel_convergence_CT_sign.jpg|100px|CT影像：血管向结节聚拢并增粗]]<br />
</div><br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">影像特征：血管聚拢 / 穿行</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">病理核心</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">[[肿瘤血管生成]] + [[纤维牵拉]]</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">关键分子</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">[[VEGF]] (血管内皮生长因子)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">恶性形态</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #b91c1c;">穿行、截断、增粗</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">良性形态</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #16a34a;">受压移位、包绕</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">常见疾病</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #1e40af;">[[肺腺癌]]</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569;">鉴别手段</th><br />
<td style="padding: 6px 12px; color: #0f172a;">[[增强CT]] / 三维重建</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">成因机制：供血与牵拉</h2><br />
<br />
<p style="margin: 15px 0; text-align: justify;"><br />
血管集束征的形成并非偶然，它是肿瘤主动改变微环境的结果。主要涉及两个病理过程：<br />
</p><br />
<br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>新生血管生成 (Angiogenesis)：</strong> <br />
<br>肿瘤细胞分泌大量 <strong>[[VEGF]]</strong> 等因子，诱导周围血管向肿瘤方向生长、发出分支。这些血管不仅数量增加，而且管径常发生代偿性<strong>增粗</strong>，以满足肿瘤的高代谢需求。</li><br />
<li style="margin-bottom: 12px;"><strong>纤维化牵拉 (Desmoplasia)：</strong> <br />
<br>肿瘤内部的纤维结缔组织增生和收缩，产生向心力，将周围原本走行正常的肺血管“拽”向病灶中心。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">影像分型：血管与结节的关系</h2><br />
<br />
<div style="background-color: #f0f9ff; border-left: 5px solid #1e40af; padding: 15px 20px; margin: 20px 0; border-radius: 4px;"><br />
<h3 style="margin-top: 0; color: #1e40af; font-size: 1.1em;">分型的临床意义</h3><br />
<p style="margin-bottom: 0; text-align: justify; font-size: 0.95em; color: #334155;"><br />
并非所有血管集束都提示恶性。根据血管与病灶的空间关系，可分为四种类型，其恶性风险由高到低依次为：穿行 > 截断 > 边缘 > 推移。<br />
</p><br />
</div><br />
<br />
<div style="overflow-x: auto; margin: 30px auto; max-width: 95%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.9em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 20%;">类型</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569;">影像表现</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">临床提示</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">I 型 (截断)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">血管到达肿瘤边缘或进入少许后突然中断。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">提示血管被肿瘤栓塞或破坏，恶性征象。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600; background-color: #fee2e2;">II 型 (穿行)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2;">血管直接穿过病灶，常伴有管壁不规则或<strong>管径增粗</strong>。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; background-color: #fee2e2; color: #b91c1c; font-weight: bold;">强恶性征象。提示肿瘤供血丰富。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">III 型 (推移)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">血管被病灶推挤向外移位，呈抱球状，管腔通常变窄。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">良性（如错构瘤、结核）多见，但也可见于膨胀性生长的肿瘤。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">IV 型 (邻近)</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">血管在病灶附近经过，无接触，但受牵拉略微改变走行。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">特异性较低，需结合其他征象。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">鉴别诊断：真假集束</h2><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>肺癌：</strong> <br />
<br>常表现为<strong>血管增粗</strong>进入结节，且在增强 CT 上结节显著强化。血管穿行处常为实性成分，提示浸润。</li><br />
<li style="margin-bottom: 12px;"><strong>肺结核/结核球：</strong> <br />
<br>虽然也会因纤维化产生血管牵拉，但通常血管会被包绕或推移，且管腔往往<strong>变细</strong>（因动脉内膜炎闭塞）。</li><br />
<li style="margin-bottom: 12px;"><strong>局灶性炎症：</strong> <br />
<br>血管在病灶内正常走行，无破坏或截断，抗炎治疗后随病灶吸收恢复。</li><br />
</ul><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献 [Academic Review]</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Gao F, et al. (2019).</strong> <em>Vessel convergence sign in ground-glass nodules: association with pathological subtypes of lung adenocarcinoma.</em> <strong>[[European Radiology]]</strong>. <br><br />
<span style="color: #475569;">[点评]：细化了血管集束征与 GGN 病理类型的关系，指出血管增粗穿行强烈提示微浸润或浸润性腺癌。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>Henschke CI, et al. (2002).</strong> <em>CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans.</em> <strong>[[Radiology]]</strong>. <br><br />
<span style="color: #475569;">[点评]：早期筛查研究，确认了血管集束征是判断肺小结节良恶性的独立危险因子之一。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[3] <strong>Yankelevitz DF, et al. (1999).</strong> <em>Small pulmonary nodules: evaluation with repeat CT--preliminary experience.</em> <strong>[[Radiology]]</strong>. <br><br />
<span style="color: #475569;">[点评]：探讨了血管征象在微小结节随访中的价值，指出血管连接的存在往往预示着病灶非良性增生。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
血管集束征 · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">病理基础</td><br />
<td style="padding: 10px 15px; color: #334155;">[[血管生成]] • [[VEGF]] • [[纤维化收缩]] • [[血管侵犯]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">形态分类</td><br />
<td style="padding: 10px 15px; color: #334155;">[[血管穿行]] • [[血管截断]] • [[血管受压]] • [[血管增粗]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">关联征象</td><br />
<td style="padding: 10px 15px; color: #334155;">[[磨玻璃结节]] • [[分叶征]] • [[毛刺征]] • [[强化CT]]</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle;">临床诊断</td><br />
<td style="padding: 10px 15px; color: #334155;">[[肺腺癌]] • [[结核球]] • [[错构瘤]] • [[真菌感染]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
77921020